Skip to content

LED Treatment to Improve Cognition and Promote Recovery in TBI

Noninvasive LED Treatment to Improve Cognition and Promote Recovery in Blast TBI

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02404402
Acronym
LED-TBI
Enrollment
8
Registered
2015-03-31
Start date
2015-05-01
Completion date
2027-10-31
Last updated
2024-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury, Posttraumatic Stress Disorder

Keywords

Traumatic Brain Injury, Light Emitting Diodes, Cognition, Neuromodulation, PTSD, Neurorehabilitation, Veterans, Sleep

Brief summary

This study investigates the efficacy of a novel neuromodulation treatment, light emitting diodes (LED), on cognition, neuropsychiatric status and quality of life in individuals with traumatic brain injury (TBI).

Detailed description

The most common traumatic brain injury (TBI)-associated problems are cognitive deficits and neuropsychiatric problems, such as sleep disturbance and PTSD. This study evaluates a novel neuromodulation intervention, light emitting diodes (LED), for treatment of patients with TBI. LED is a noninvasive, non-thermal, painless treatment, which does not involve any needles or any form of surgery. LED treatment improves cellular activity of the brain tissue that has been damaged by TBI. Half of the study participants will receive active LED treatment, and a control group will receive sham LED. This study takes place in Boston, Massachusetts: at the VA Boston Healthcare System.

Interventions

OTHERLED

Low Level Light Therapy

Inactive (sham) LED treatment

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

Inclusion Criteria: * OEF/OIF active-duty personnel or Veterans with history of TBI or blast-exposure * Meets criteria for mild TBI * LOC of 30 min or less * Age: 21-55 * Primary language is English

Exclusion criteria

* Evidence of penetrating head injury * History of previous neurological diagnosis * History of previous psychotic disorder prior to TBI * Hearing or vision impairment

Design outcomes

Primary

MeasureTime frameDescription
Cognitive Functioning_Attention/ExecutiveEight WeeksStroop Test (Color-Word test; Delis, Kaplan & Kramer, 2001)
Cognitive Functioning_Learning/MemoryEight weeksCalifornia Verbal Learning Test-II (CVLT-II; Delis, Kramer, Kaplan, & Ober, 2000)

Secondary

MeasureTime frameDescription
Neuropsychiatric Status/MoodEight weeksBeck Depression inventory (BDI; Beck, 2006)
Neuropsychiatric status/PTSDEight weeksPTSD Checklist - Military Version (PCL-M)
Neuropsychiatric status/SleepEight weeksPittsburgh Sleep Quality Index (PSQI; Buysse et al., 1989)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026